[Effectiveness of fenalgin SPOFA in lumboischiadic syndrome (author's transl)].
D000082:Acetaminophen / Q000627:therapeutic use*; D000328:Adult; D001241:Aspirin / Q000627:therapeutic use*; D001416:Back Pain / Q000188:drug therapy*; D002110:Caffeine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003061:Codeine / Q000627:therapeutic use*; D011431:Dextropropoxyphene / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010634:Phenobarbital / Q000627:therapeutic use*; D012585:Sciatica / Q000188:drug therapy*; D013577:Syndrome
D004338:Drug Combinations; D000082:Acetaminophen; D002110:Caffeine; C019383:fenalgin; D001241:Aspirin; D011431:Dextropropoxyphene; D003061:Codeine; D010634:Phenobarbital
Ucinnost fenalginu SPOFA pri lumboischiadickom syndróme.